Imipenem/Cilastatin/Relebactam PK in ECMO

NCT04493151 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Imipenem, Cilastatin and Relebactam

Sponsor

Joseph L. Kuti, PharmD

Collaborators

[object Object]